Vertex Pharmaceutical’s year-to-date stock performance.
vertex pharmaceuticals: “I think Vertex is very strong. I wish I had bought it for my charitable trust a long time ago when the CEO was in office. It was a great decision, but it has since faded. It was a mistake. It was a good buy.”
Oddity Tech’s year-to-date stock performance.
Oddity Tech“Frankly, that industry is… too hard. And it was my fault that I didn’t realize how hard it was when I put them on the show. I thought they told a really good story, but the story just didn’t work out.”
ImmunityBio’s year-to-date stock performance.
immune bio“It’s not clear exactly what they did wrong, but they got into trouble. I had to see how they got out of trouble. And we’re going to investigate it thoroughly.”
Aehr Test Systems’ year-to-date stock performance.
Aehr test system: “The stock price has gone up too much. It’s gone parabolic. We have to wait. I wish I didn’t have to say it, but we have to wait.”
Copart’s stock price performance year-to-date.
copalt：”I’d like to buy that stock, but it’s too cheap…It looks like I’m buying at the bottom.”
